• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    H

    Hospital General de México,Secretaria de Salud

    EST. 1905
    3,085论文总数
    5.8万引用总数

    The General Hospital of Mexico (Hospital General de México, HGM) is a hospital in Mexico City, operated by the Secretariat of Health, the federal government department in charge of all social health services in Mexico..

    论文量&引用量时间轴

    机构学者

    论文(3085)

    年份
    起
    –
    止
    排序
    1Metabolic Effect of the Emergent Pollutant and Endocrine Disruptor Bisphenol A in Male BALBc/AnN Mice
    Karen Elizabeth Nava-Castro, Valeria Lopez Salazar,Mariana Segovia-Mendoza,Galileo Escobedo, Gustavo Pacheco Lopez, Martha Patricia Sierra-Vargas,Armando Perez-Torres,Javier Velazquez-Moctezuma,Manuel Ivan Giron-Perez,Antonio Gonzalez-Chavez,Jorge Morales-Montor

    Background. Bisphenol A (BPA) is an endocrine-disrupting chemical with estrogenic properties that affects various tissues. It has been linked to chronic and inflammatory diseases, such as diabetes and metabolic syndrome. Aim. To investigate the obesogenic effects of a single neonatal administration of BPA on obesity and its underlying mechanisms in mice. Methods. We established a neonatal BPA administration model in mice and measured various biochemical parameters. We also analyzed retroperitoneal, mesenteric, and gonadal fat depots using magnetic resonance imaging (MRI). In addition, to provide a translational context, we measured the serum BPA levels in male obese patients. Results. Neonatal BPA administration in mice induced chronic dimorphic obesity and metabolic syndrome only in male mice. These findings were also reproducible in obese male patients, who exhibited higher concentrations of this endocrine-disrupting chemical than their non-obese counterparts. In addition, the results showed that the number of adult male mice was significantly higher in the BPA-treated group compared with the control and vehicle groups. Metabolic and biochemical parameters, such as adipose tissue, cholesterol, triglycerides, and glucose, were also significantly higher in mice that received BPA in the neonatal stage. Conclusion. Single neonatal BPA administration could be used as a novel strategy in the study of obesity. (c) 2026 The Author(s). Published by Elsevier Inc. on behalf of Instituto Mexicano del Seguro Social (IMSS). This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/)

    2027ARCHIVES OF MEDICAL RESEARCH(2027)
    引用
    AI阅读
    加入学术空间
    2Cutaneous Coccidioidomycosis and Climate Change
    Eduardo García-Salazar,Alexandro Bonifaz, Paola Betancourt-Cisneros,María Guadalupe Frías-De-León

    To review the current literature to understand and analyze the impact of climate change on the spatial dynamics of primary cutaneous coccidioidomycosis. Establishing a causal relationship between climate change and the incidence of primary cutaneous coccidioidomycosis is challenging due to the low number of reported cases. Strong evidence that climate change has altered the epidemiology of pulmonary coccidioidomycosis suggests the same impact on cutaneous infection. Global warming, climate migration, and extreme weather events have led to changes in the spatial dynamics of coccidioidomycosis, both in its pulmonary and primary cutaneous forms, despite being a rare clinical entity. Currently, primary cutaneous coccidioidomycosis should be considered in the differential diagnosis of unusual skin lesions that occur in people living in areas traditionally known to be endemic, as well as in those that are not.

    2026Current Fungal Infection Reports(2026)引用:53
    引用
    AI阅读
    加入学术空间
    3Cutaneous Coccidioidomycosis: Diagnosis and Treatment. State of the Art
    Luisa F. Martínez-Rosas-Híjar, Julieta Loya-Acosta, Regina Rojas-García,Gloria M. González,Andrés Tirado-Sánchez, Valeria Díaz-Molina,Alexandro Bonifaz

    The review summarizes the existing literature on epidemiology, pathogenesis, the clinical spectrum, and manifestations, as well as diagnostic testing and treatment of coccidioidomycosis, and discusses the role of cutaneous manifestations in facilitating early diagnosis. The recent literature emphasizes a variety of clinical manifestations, confirms the added value of combining histopathology/serology, culture, and molecular tests to increase diagnosis accuracy, but also reinforces triazoles as the first-line therapy. Increasing evidence also highlights the host Th1 and Th17 immune response, as well as genomic virulence factors, as key drivers of disease heterogeneity. Early identification of cutaneous signs is crucial for effective treatment, limiting the spread of the disease, and improving outcomes. Severe or refractory disease often requires amphotericin B. Future research should focus on refining rapid diagnostics, risk prediction, and optimized antifungal regimens in both endemic and nonendemic settings. These priorities may guide prospective studies and standardized management pathways to enhance outcomes in diverse populations worldwide.

    2026Current Fungal Infection Reports(2026)引用:45
    引用
    AI阅读
    加入学术空间
    4The Influence of the Gut Microbiome on Malassezia-Associated Diseases. the Classic Gut-Skin Axis Revisited
    Marcela Velarde-Loya, Julieta Loya-Acosta,Andrés Tirado-Sánchez, Valeria Díaz-Molina, Esaú López-Jácome,Alexandro Bonifaz

    To examine current evidence regarding the bidirectional communication within the gut–brain–skin axis, the impact of microbiome dysbiosis on immune regulation, and its contribution to the development of inflammatory dermatoses, particularly those linked to Malassezia species. Emerging research supports a dynamic interaction between the intestinal and cutaneous microbiome, demonstrating that alterations in gut microbial composition can influence systemic immune responses and skin inflammation. Dysbiosis has been associated with increased intestinal permeability, systemic inflammatory signaling, and exacerbation of dermatologic conditions such as acne, psoriasis, atopic dermatitis, alopecia areata, and Malassezia-associated disorders. Additionally, psychosocial stress and dietary factors have been shown to modulate this axis. The gut–brain–skin axis represents a complex regulatory network in which microbial homeostasis plays a central role in maintaining immune balance and skin health. Disruption of this equilibrium may contribute to inflammatory and Malassezia-associated skin diseases. A deeper understanding of these interactions may open new avenues for microbiome-targeted therapeutic strategies.

    2026Current Fungal Infection Reports(2026)引用:30
    引用
    AI阅读
    加入学术空间
    5A Structured Approach for Treatment Selection in Chronic Lymphocytic Leukemia: A Multiregional Expert Consensus
    Guilherme Fleury Perini, Ahmad Alhuraiji,Mary Ann Anderson, Gilberto Israel Barranco Lampón, Otavio Cesar Carvalho Guimarães Baiocchi,Ahmet Emre Eşkazan,Yeow Tee Goh,Wei-Han Huang,Mervat Mattar,Eugene Nikitin,Stephen Opat, Miguel A. Pavlovsky,

    The treatment landscape for Chronic Lymphocytic Leukemia has rapidly evolved from chemoimmunotherapy to highly effective targeted agents. Despite superior efficacy and safety profiles of these novel agents, challenges persist, particularly due to limited head-to-head trials and regional differences in drug availability and molecular testing. This multiregional expert consensus, developed by 13 hematology experts from Latin America, the Middle East and Africa, Asia-Pacific, and Russia using an adapted Delphi approach, provides evidence-informed recommendations for first-line treatment and sequencing tailored to patient risk and real-world resource constraints. The panel agreed on 16 key statements, emphasizing that targeted therapies are preferred for nearly all newly diagnosed patients. Molecular testing for del(17p), TP53 mutation, and IGHV status is recommended for prognosis and treatment planning. High-risk patients (del(17p) and/or TP53 mutation) should preferably receive continuous therapy with second-generation BTK inhibitors (acalabrutinib or zanubrutinib), which are generally preferred over ibrutinib due to safety advantages. Low-risk patients (IGHV-mutated, without del(17p)/TP53) are best suited for time-limited, venetoclax-based regimens. Upon relapse, switching therapeutic classes is recommended: venetoclax after continuous BTKi therapy, and BTKi after fixed-duration venetoclax. Overall, the consensus underscores the importance of individualized, shared decision-making that accounts for molecular risk, comorbidities, and patient preferences, while highlighting global disparities in access to modern CLL therapies.

    2026Blood Global Hematology(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 3085 篇论文

    合作机构(100)

    墨西哥国立自治大学合作论文 234
    墨西哥社会保障研究所合作论文 229
    Instituto Nacional de Salud Pública,Secretaria de Salud合作论文 93
    Instituto Nacional de Cancerología,Secretaria de Salud合作论文 58
    Universidad Autónoma de Nuevo León合作论文 46
    Centro Médico ABC合作论文 43
    Hospital Infantil de México Federico Gómez合作论文 41
    Instituto Politécnico Nacional合作论文 37
    Hospital General Dr. Manuel Gea Gonzalez,Secretaria de Salud合作论文 36
    Hospital Juárez de México合作论文 34

    机构统计